日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Malignant JAK-signaling: at the interface of inflammation and malignant transformation

恶性JAK信号通路:炎症与恶性转化的交汇点

Perner, Florian; Pahl, Heike L; Zeiser, Robert; Heidel, Florian H

Lysine-specific demethylase 1 regulates hematopoietic stem cell expansion and myeloid cell differentiation.

赖氨酸特异性去甲基化酶 1 调节造血干细胞扩增和髓系细胞分化

Staehle Hans Felix, Koellerer Christoph, Staehle Anne Marie, Schulze Jana, Eble Philipp, Müller Anja, Zell Franziska, Müller Judith M, Perner Florian, Attia Aya, Mallm Jan-Philipp, Pozdnyakova Olga, Rippe Karsten, Brors Benedikt, Feuerbach Lars, Imbusch Charles D, Metzger Eric, Schüle Roland, Pahl Heike L, Jutzi Jonas S

NFE2 Truncation Mutants Protect Wild-Type NFE2 from ITCH-Dependent Degradation

NFE2截短突变体保护野生型NFE2免受ITCH依赖性降解

Hoeness, Mirjam Elisabeth; Zell, Franziska; Basu, Titiksha; Gellrich, Katharina; Gründer, Albert; Schulze, Jana; Müller, Anja; Eble, Philipp; Koellerer, Christoph; Staehle, Anne Marie; Bojtine Kovacs, Sarolta; Pahl, Heike L; Staehle, Hans Felix

Response to PD-1 inhibition in MMRd/MSS pancreatic ductal adenocarcinoma: the relevance of parallel testing

MMRd/MSS型胰腺导管腺癌对PD-1抑制剂的反应:平行试验的意义

Pahl, Heike L; Lassmann, Silke; Schultheis, Anne M; Rau, Stephan; Börries, Melanie; Duyster, Justus; Zaiss, Matthias; Quante, Michael; Becker, Heiko

Final Results From a Large, Non-Interventional, Phase 4 Study of Ruxolitinib for the Treatment of Myelofibrosis in Clinical Routine

鲁索替尼治疗骨髓纤维化的大型非干预性4期临床常规研究的最终结果

Koschmieder, Steffen; Isfort, Susanne; Schulte, Clemens; Jacobasch, Lutz; Geer, Thomas; Reiser, Marcel; Koenigsmann, Michael; Heinrich, Bernhard; Wehmeyer, Jürgen; von der Heyde, Eyck; Tesch, Hans; Gröschl, Benedikt; Bachhuber, Petra; Großer, Susanne; Koehler, Michael; Pahl, Heike L

Oncogene-induced TIM-3 ligand expression dictates susceptibility to anti-TIM-3 therapy in mice

癌基因诱导的TIM-3配体表达决定了小鼠对TIM-3抑制剂疗法的敏感性。

Talvard-Balland, Nana; Braun, Lukas M; Dixon, Karen O; Zwick, Melissa; Engel, Helena; Hartmann, Alina; Duquesne, Sandra; Penter, Livius; Andrieux, Geoffroy; Rindlisbacher, Lukas; Acerbis, Andrea; Ehmann, Jule; Köllerer, Christoph; Ansuinelli, Michela; Rettig, Andres; Moschallski, Kevin; Apostolova, Petya; Brummer, Tilman; Illert, Anna L; Schramm, Markus A; Cheng, Yurong; Köttgen, Anna; Duyster, Justus; Menssen, Hans D; Ritz, Jerome; Blazar, Bruce R; Boerries, Melanie; Schmitt-Gräff, Annette; Sariipek, Nurefsan; Van Galen, Peter; Buescher, Joerg M; Cabezas-Wallscheid, Nina; Pahl, Heike L; Pearce, Erika L; Soiffer, Robert J; Wu, Catherine J; Vago, Luca; Becher, Burkhard; Köhler, Natalie; Wertheimer, Tobias; Kuchroo, Vijay K; Zeiser, Robert

Real-world analysis of ruxolitinib in myelofibrosis: interim results focusing on patients who were naïve to JAK inhibitor therapy treated within the JAKoMo non-interventional, phase IV trial

鲁索替尼治疗骨髓纤维化的真实世界分析:JAKoMo非干预性IV期试验中既往未接受过JAK抑制剂治疗的患者的中期结果

Koschmieder, Steffen; Isfort, Susanne; Schulte, Clemens; Jacobasch, Lutz; Geer, Thomas; Reiser, Marcel; Koenigsmann, Michael; Heinrich, Bernhard; Wehmeyer, Jürgen; von der Heyde, Eyck; Tesch, Hans; Gröschl, Benedikt; Bachhuber, Petra; Großer, Susanne; Pahl, Heike L

Kidney Dysfunction Is Associated with Thrombosis and Disease Severity in Myeloproliferative Neoplasms: Implications from the German Study Group for MPN Bioregistry

肾功能障碍与骨髓增生性肿瘤的血栓形成和疾病严重程度相关:来自德国骨髓增生性肿瘤生物登记研究组的启示

Gecht, Judith; Tsoukakis, Ioannis; Kricheldorf, Kim; Stegelmann, Frank; Klausmann, Martine; Griesshammer, Martin; Schulz, Holger; Hollburg, Wiebke; Göthert, Joachim R; Sockel, Katja; Heidel, Florian H; Gattermann, Norbert; Maintz, Christoph; Al-Ali, Haifa K; Platzbecker, Uwe; Hansen, Richard; Hänel, Mathias; Parmentier, Stefani; Bommer, Martin; Pahl, Heike L; Lang, Fabian; Kirschner, Martin; Isfort, Susanne; Brümmendorf, Tim H; Döhner, Konstanze; Koschmieder, Steffen

Epigenetic regulation of NFE2 overexpression in myeloproliferative neoplasms

骨髓增生性肿瘤中NFE2过表达的表观遗传调控

Peeken, Jan C; Jutzi, Jonas S; Wehrle, Julius; Koellerer, Christoph; Staehle, Hans F; Becker, Heiko; Schoenwandt, Elias; Seeger, Thalia S; Schanne, Daniel H; Gothwal, Monika; Ott, Christopher J; Gründer, Albert; Pahl, Heike L

Oncogenic JAK2(V617F) causes PD-L1 expression, mediating immune escape in myeloproliferative neoplasms

致癌性JAK2(V617F)导致PD-L1表达,介导骨髓增生性肿瘤的免疫逃逸。

Prestipino, Alessandro; Emhardt, Alica J; Aumann, Konrad; O'Sullivan, David; Gorantla, Sivahari P; Duquesne, Sandra; Melchinger, Wolfgang; Braun, Lukas; Vuckovic, Slavica; Boerries, Melanie; Busch, Hauke; Halbach, Sebastian; Pennisi, Sandra; Poggio, Teresa; Apostolova, Petya; Veratti, Pia; Hettich, Michael; Niedermann, Gabriele; Bartholomä, Mark; Shoumariyeh, Khalid; Jutzi, Jonas S; Wehrle, Julius; Dierks, Christine; Becker, Heiko; Schmitt-Graeff, Annette; Follo, Marie; Pfeifer, Dietmar; Rohr, Jan; Fuchs, Sebastian; Ehl, Stephan; Hartl, Frederike A; Minguet, Susana; Miething, Cornelius; Heidel, Florian H; Kröger, Nicolaus; Triviai, Ioanna; Brummer, Tilman; Finke, Jürgen; Illert, Anna L; Ruggiero, Eliana; Bonini, Chiara; Duyster, Justus; Pahl, Heike L; Lane, Steven W; Hill, Geoffrey R; Blazar, Bruce R; von Bubnoff, Nikolas; Pearce, Erika L; Zeiser, Robert